Rockefeller Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$713K Buy
84,165
+5,000
+6% +$42.4K ﹤0.01% 1443
2025
Q1
$636K Sell
79,165
-35
-0% -$281 ﹤0.01% 1407
2024
Q4
$711K Buy
79,200
+35
+0% +$314 ﹤0.01% 1365
2024
Q3
$580K Sell
79,165
-159
-0.2% -$1.17K ﹤0.01% 1390
2024
Q2
$453K Buy
79,324
+159
+0.2% +$908 ﹤0.01% 1469
2024
Q1
$397K Sell
79,165
-2,005
-2% -$10K ﹤0.01% 1531
2023
Q4
$730K Buy
81,170
+5
+0% +$45 ﹤0.01% 1247
2023
Q3
$631K Hold
81,165
﹤0.01% 1237
2023
Q2
$786K Hold
81,165
﹤0.01% 1176
2023
Q1
$889K Buy
81,165
+2,000
+3% +$21.9K ﹤0.01% 1123
2022
Q4
$341K Hold
79,165
﹤0.01% 1423
2022
Q3
$595K Hold
79,165
﹤0.01% 1204
2022
Q2
$795K Hold
79,165
﹤0.01% 1073
2022
Q1
$980K Hold
79,165
﹤0.01% 1061
2021
Q4
$1.81M Sell
79,165
-14,420
-15% -$330K 0.01% 833
2021
Q3
$2.07M Buy
93,585
+500
+0.5% +$11.1K 0.01% 736
2021
Q2
$1.21M Hold
93,085
0.01% 864
2021
Q1
$1.21M Hold
93,085
0.01% 726
2020
Q4
$1.29M Sell
93,085
-1,000
-1% -$13.8K 0.01% 631
2020
Q3
$1.39M Hold
94,085
0.01% 517
2020
Q2
$1.53M Buy
94,085
+1,000
+1% +$16.3K 0.02% 453
2020
Q1
$1.35M Hold
93,085
0.02% 409
2019
Q4
$1.89M Hold
93,085
0.02% 357
2019
Q3
$497K Buy
93,085
+1,500
+2% +$8.01K 0.01% 492
2019
Q2
$603K Hold
91,585
0.01% 416
2019
Q1
$595K Hold
91,585
0.01% 456
2018
Q4
$625K Buy
+91,585
New +$625K 0.01% 294